News Posts in February, 2024 Feb 15 2024 Novel Drug ADI-PEG20 in Breakthrough Clinical Trial Extends Survival in Mesothelioma Patients An international randomized clinical trial led by Queen Mary University of London implementing the new drug ADI-PEG20 (pegargiminase) demonstrated an increase in average survival by 1.6 months and quadrupled the three-year survival rate of ... Continue Reading...